Asymchem acquires former Pfizer small molecule API pilot plant in Sandwich, UK
Establishing Asymchem’s first manufacturing footprint in Europe
Establishing Asymchem’s first manufacturing footprint in Europe
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
CMOs showed an increasing reluctance to take on debt in 2022
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Subscribe To Our Newsletter & Stay Updated